PROFUND ADVISORS LLC - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$622,978
-32.7%
38,839
-2.7%
0.03%
-32.0%
Q2 2023$925,462
+9.5%
39,925
+9.7%
0.05%
-3.8%
Q1 2023$845,502
+282.6%
36,397
+315.4%
0.05%
+477.8%
Q1 2022$221,000
-0.9%
8,761
+8.3%
0.01%
+28.6%
Q4 2021$223,000
-17.4%
8,089
-3.1%
0.01%
-22.2%
Q3 2021$270,000
-15.9%
8,348
-20.4%
0.01%
-18.2%
Q2 2021$321,000
+10.3%
10,490
+9.6%
0.01%0.0%
Q1 2021$291,000
+17.3%
9,572
-56.3%
0.01%
-21.4%
Q2 2020$248,000
-6.4%
21,893
+18.2%
0.01%
-30.0%
Q1 2020$265,000
-63.6%
18,521
-30.8%
0.02%
-37.5%
Q4 2019$729,000
-3.2%
26,762
+1.8%
0.03%
-15.8%
Q3 2019$753,000
+9.8%
26,289
+6.5%
0.04%
+15.2%
Q2 2019$686,000
-24.6%
24,683
-10.0%
0.03%
-25.0%
Q1 2019$910,000
+7.9%
27,413
-5.5%
0.04%
-15.4%
Q4 2018$843,000
-51.3%
29,013
-22.9%
0.05%
-21.2%
Q3 2018$1,731,000
+25.1%
37,625
+1.6%
0.07%
+20.0%
Q2 2018$1,384,000
+26.9%
37,025
+0.3%
0.06%
+27.9%
Q1 2018$1,091,000
-10.7%
36,918
+3.8%
0.04%
-8.5%
Q4 2017$1,222,000
-15.7%
35,582
-11.2%
0.05%
-21.7%
Q3 2017$1,450,000
+55.7%
40,084
+11.3%
0.06%
+42.9%
Q2 2017$931,000
+14.8%
36,028
-14.7%
0.04%
+16.7%
Q1 2017$811,000
+48.3%
42,215
+28.6%
0.04%
+44.0%
Q4 2016$547,000
-29.4%
32,814
-12.8%
0.02%
-32.4%
Q3 2016$775,000
-35.9%
37,635
-4.8%
0.04%
-37.3%
Q2 2016$1,209,000
-23.4%
39,525
-6.2%
0.06%
-28.0%
Q1 2016$1,578,000
-28.2%
42,154
-17.3%
0.08%
-21.2%
Q4 2015$2,199,000
+14.5%
50,947
-0.6%
0.10%
-4.6%
Q3 2015$1,921,000
+3.9%
51,243
-5.8%
0.11%
+41.6%
Q2 2015$1,849,000
-2.4%
54,401
+1.7%
0.08%
+4.1%
Q1 2015$1,894,000
+6.9%
53,490
+2.8%
0.07%
+1.4%
Q4 2014$1,772,000
-1.2%
52,037
+12.0%
0.07%
-13.1%
Q3 2014$1,793,000
+5.0%
46,481
+5.9%
0.08%
+12.0%
Q2 2014$1,708,000
-7.0%
43,896
-18.3%
0.08%
-9.6%
Q1 2014$1,836,000
+93.7%
53,707
+18.9%
0.08%
+97.6%
Q4 2013$948,000
+2.9%
45,184
+15.3%
0.04%
-14.3%
Q3 2013$921,000
-8.2%
39,183
+5.0%
0.05%
-31.0%
Q2 2013$1,003,00037,3170.07%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 6,635,000$106,4253.51%
Glenview Capital Management 3,783,982$60,695,0711.37%
AMH Equity Ltd 47,285$758,4510.83%
DISCIPLINED GROWTH INVESTORS INC /MN 1,973,312$31,651,9240.75%
EARNEST PARTNERS LLC 3,473,281$55,711,4270.32%
AIMZ Investment Advisors, LLC 40,985$657,3990.29%
PEREGRINE CAPITAL MANAGEMENT LLC 280,767$4,503,5030.13%
Beverly Hills Private Wealth, LLC 19,687$315,7790.09%
Artisan Partners Limited Partnership 2,537,147$40,695,8380.07%
Jump Financial, LLC 84,924$1,362,1810.05%
View complete list of MYRIAD GENETICS INC shareholders